These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women. McCormack PL; Joura EA BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years. Yoshikawa H; Ebihara K; Tanaka Y; Noda K Cancer Sci; 2013 Apr; 104(4):465-72. PubMed ID: 23331518 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. FUTURE II Study Group J Infect Dis; 2007 Nov; 196(10):1438-46. PubMed ID: 18008221 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. McIntosh J; Sturpe DA; Khanna N J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123 [TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and vaccination in cervical cancer. Wang KL Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340 [TBL] [Abstract][Full Text] [Related]
10. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. ; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284 [TBL] [Abstract][Full Text] [Related]
11. A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls. Draper E; Bissett SL; Howell-Jones R; Waight P; Soldan K; Jit M; Andrews N; Miller E; Beddows S PLoS One; 2013; 8(5):e61825. PubMed ID: 23650505 [TBL] [Abstract][Full Text] [Related]
12. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women. McCormack PL; Joura EA Drugs; 2010 Dec; 70(18):2449-74. PubMed ID: 21142263 [TBL] [Abstract][Full Text] [Related]
13. Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix. Schwarz TF Adv Ther; 2009 Nov; 26(11):983-98. PubMed ID: 20024678 [TBL] [Abstract][Full Text] [Related]
15. The HPV vaccine: a content analysis of online news stories. Habel MA; Liddon N; Stryker JE J Womens Health (Larchmt); 2009 Mar; 18(3):401-7. PubMed ID: 19281323 [TBL] [Abstract][Full Text] [Related]
16. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM Cancer Prev Res (Phila); 2009 Oct; 2(10):868-78. PubMed ID: 19789295 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccines: current status and future prospects. Garland SM; Smith JS Drugs; 2010 Jun; 70(9):1079-98. PubMed ID: 20518577 [TBL] [Abstract][Full Text] [Related]
18. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Schiller JT; Castellsagué X; Villa LL; Hildesheim A Vaccine; 2008 Aug; 26 Suppl 10(Suppl 10):K53-61. PubMed ID: 18847557 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Broomall EM; Reynolds SM; Jacobson RM Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463 [TBL] [Abstract][Full Text] [Related]
20. HPV vaccines - A review of the first decade. Harper DM; DeMars LR Gynecol Oncol; 2017 Jul; 146(1):196-204. PubMed ID: 28442134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]